|
| GSK 2239633A Basic information |
Product Name: | GSK 2239633A | Synonyms: | GSK 2239633A;Propanamide, N-[[3-[[3-[[(5-chloro-2-thienyl)sulfonyl]amino]-4-methoxy-1H-indazol-1-yl]methyl]phenyl]methyl]-2-hydroxy-2-methyl-;GSK-2239633A,inhibit,Inhibitor,CC chemokine receptor,CCR,GSK2239633A;N-[(3-{[3-{[(5-Chloro-2-thienyl)sulfonyl]amino}-4-(methyloxy)-1H-indazol-1-yl]methyl}phenyl)methyl]-2-hydroxy-2-methylpropanamide | CAS: | 1240516-71-5 | MF: | C24H25ClN4O5S2 | MW: | 549.06 | EINECS: | | Product Categories: | | Mol File: | 1240516-71-5.mol | |
| GSK 2239633A Chemical Properties |
density | 1.45±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:152.46(Max Conc. mg/mL);277.67(Max Conc. mM) | pka | 7.03±0.30(Predicted) |
| GSK 2239633A Usage And Synthesis |
Uses | GSK 2239633A, is an allosteric antagonist of human CCR4. | storage | Store at -20°C |
| GSK 2239633A Preparation Products And Raw materials |
|